Trenbolone Hexahydrobenzylcarbonate
custom order
Being highly androgenic, trenbolone has the capacity to almost immediately stop the production of endogenous testosterone. Trenbolone hexahydrobenzylcarbonate was marketed in France for medical use in humans but has since been discontinued. It was introduced in in 1980 but was voluntarily discontinued by its manufacturer in 1997. Trenbolone hexahydrobenzylcarbonate half-life is approximately 14 days. The drug acts as a long-lacting prodrug of trenbolone when administered via intramuscular injection.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
To leave a comment: